2nd ProCAncer-I Project Dissemination Event in Lisbon

Published on: May 11, 2023
Categories: Events | News

We are really happy to be part of the “AI and Machine Learning in Cancer Imaging 3.0 – Enhancing Healthcare through AI” event on 30th June & 1st July 2023 in Lisbon, Portugal. The event is organised jointly by the Champalimaud Foundation and the International Cancer Imaging Society. It aims to promote the better understanding and application of AI and machine learning in cancer imaging, and provide a multidisciplinary forum for radiologists, technicians/ radiographers, scientists and industry partners to discuss and interact.

A special Session will take place, presenting and discussing on the ProCAncer-I project with the title: “The best practices on machine learning for multicentric approaches”

We would be delighted to meet you and discuss your questions!

 

For more information about the Congress and registration: https://www.icimagingsociety.org.uk/index.cfm?task=meetings&meetingid=290

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!